Lung and Heart-Lung Transplantation: A Review of Progress and Current Status based on the Registry of the International Society for Heart and Lung Transplantation

  • G. B. Haasler
  • J. D. Hosenpud


The past decade has witnessed the rise of lung transplantation (LTx) as a viable clinical entity, and has seen substantial revisions in the concepts underlying the techniques and indications for LTx and heart-lung transplantation (HLTx). From rather inauspicious beginnings in the late 1960s and 1970s, LTx has emerged as a modality useful for treating both end-stage primary lung disease in a variety of settings[1]’[17] and the pulmonary sequelae of congenital heart disease[4],[7],[15],[18]’[21]. Over 500 single lung, 300 double lung, and 100 heart-lung transplants were carried out in 1994 (Figures 1-3). Single (SLTx) and double (or, more correctly, bilateral single) (DLTx) lung transplantation have resulted in substantial reversibility of right heart dysfunction secondary to pulmonary vascular disease in both primary and secondary pulmonary hypertension, allowing preservation of the patient’s own heart where formerly HLTx was considered a necessity[19],[22]. This has resulted in a significant reduction in the number of heart-lung transplants yearly (Figure 3). In addition, the routine use of DLTx in septic conditions, such as cystic fibrosis and bronchiectasis, has demonstrated that transplantation and immunosuppression can be carried out in a unique setting of infection where significant residual bacterial colonization still exists in other body reservoirs[2],[23],[24].


Cystic Fibrosis Pulmonary Hypertension Idiopathic Pulmonary Fibrosis Lung Transplantation Cystic Fibrosis Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Caine N, Sharpies LD. Smyth R et al. Survival and quality of life of cystic fibrosis patients before and after heart-lung transplantation. Transplant. Proc. 1991;23:1203–4.PubMedGoogle Scholar
  2. 2.
    Cppper JD. The evolution of techniques and indications for lung transplantation. Ann Surg. 1990;212:249–56.CrossRefGoogle Scholar
  3. 3.
    Egan TM. Lung preservation. Semin Thorac Cardiovasc Surg. 1992;4:83–9.PubMedGoogle Scholar
  4. 4.
    Egan TM, Kaiser LR, Cooper JD. Lung transplantation. Curr Probl Surg. 1989;26:673–752.PubMedCrossRefGoogle Scholar
  5. 5.
    Emery RW, Grail JL, Hale K et al. Treatment of end-stage chronic obstructive pulmonary disease with double lung transplantation. Chest. 1991;99:533–7.PubMedGoogle Scholar
  6. 6.
    Frost AK, Keller CA, Brown RW et al. Giant cell interstitial pneumonitis: disease recurrence in the transplanted lung. Am Rev Respir Dis. 1993:148:1401–4.PubMedGoogle Scholar
  7. 7.
    Hosenpud JD, Novick RJ, Breen TJ, Daily OP. The Registry of the International Society for Heart and Lung Transplantation: Eleventh Official Report-1994. J Heart Lung Transplant. 1994;13:561–70.PubMedGoogle Scholar
  8. 8.
    Grossman RF, Frost A, Zamel N and the Toronto Lung Transplant Group. Results of single-lung transplantation for bilateral pulmonary librosis. N Engl J Med. 1990;322:727–33.PubMedCrossRefGoogle Scholar
  9. 9.
    Hale K, Pritzker MR. The single lung and double lung recipient: patient selection. Cardiac Surgery: State of the Art Reviews. 1988;2:571–4.Google Scholar
  10. 10.
    Hosenpud JD, Novick RJ, Breen TJ, Daily OP. The Registry of the International Society for Heart and Lung Transplantation: Twelfth Official Report-1995. J Heart Lung Transplant. 1995;14:805–15.PubMedGoogle Scholar
  11. 11.
    Johnson BA, Duncan SR, Ohori NP et al. Recurrence of sarcoidosis in pulmonary allograft recipients. Am Rev Respir Dis. 1993;148:1373–7.PubMedGoogle Scholar
  12. 12.
    Kaiser LR, Cooper JD, Trulock EP and the Washington University Lung Transplant Group. The evolution of single lung transplantation for emphysema. J Thorac Cardiovasc Surg. 1991;102:333–11.PubMedGoogle Scholar
  13. 13.
    Mal H, Andreassian B, Pamela F et al. Unilateral lung transplantation in end-stage pulmonary emphysema. Am Rev Respir Dis. 1989;140:797–802.PubMedGoogle Scholar
  14. 14.
    McGregor CGA, Dark JH, Hilton CJ et al. Early results of single lung transplantation in patients with end-stage pulmonary librosis. J Thorac Cardiovasc Surg. 1989;98:350–4.PubMedGoogle Scholar
  15. 15.
    Spray TL, Huddleston CB. Pediatric lung transplantation Chest Surg Clin N Am. 1993;3:123–43.Google Scholar
  16. 16.
    Toronto Lung Transplant Group. Experience with single-lung transplantation for pulmonary fibrosis. J Am Med Assoc. 1988;259:2258–62.CrossRefGoogle Scholar
  17. 17.
    Toronto Lung Transplant Group. Unilateral lung transplantation for pulmonary fibrosis. N Engl J Med. 1986;314:1140–5.CrossRefGoogle Scholar
  18. 18.
    Aranki S, Musumeci F, Khaghani A, Radley-Smith R, Yacoub M. One-stage correction of interrupted aortic arch combined with heart-lung transplantation. J Thorac Cardiovasc Surg. 1989;98:285–8.PubMedGoogle Scholar
  19. 19.
    Chapelier A, Vouhe P, Macchiarini P et al. Comparative outcome of heart-lung and lung transplantation for pulmonary hypertension. J Thorac Cardiovasc Surg. 1993;106:299–307.PubMedGoogle Scholar
  20. 20.
    McCarthy PM, Rosenkranz ER, White RD, et al. Single-lung transplantation with atrial septal defect repair for Eiscnmenger’s syndrome. Ann Throac Surg. 1991;52:300–3.CrossRefGoogle Scholar
  21. 21.
    Freines SE, Patterson GA, Williams WG and the Toronto Lung Transplant Group. Single lung transplant and closure of patent ductus arteriosus for Eisenmenger’s syndrome. J Thorac Cardiovasc Surg. 1992;104:529–30.Google Scholar
  22. 22.
    Bando K, Armitage JM, Paradis IL et al. Indications for and results of single, bilateral, and heart-lung transplantation for pulmonary hypertension. J Thorac Cardiovasc Surg. 1994;108:1056–65.PubMedGoogle Scholar
  23. 23.
    de Levai MR, Smyth R, Whitehcad Bet al. Heart and lung transplantation for terminal cystic fibrosis. J Thorac Cardiovasc Surg. 1991;101:633–42.Google Scholar
  24. 24.
    Frist WH, Fox MD, Campbell PW et al. Cystic fibrosis treated with heart-lung transplantation: North American results. Transplant Proc. 1991;23:1205–6.PubMedGoogle Scholar
  25. 25.
    Calhoon JH, Nichols L, Davis R et al. Single lung transplantation: factors in post-operative cytomegalovirus infection. J Thorac Cardiovase Surg. 1992;103:21–6.Google Scholar
  26. 26.
    Calhoon JH, Grover FL, Gibbons WJ et al. Single lung transplantation-alternative indications and technique. J Thorac Cardiovasc Surg. 1991; 101:816–25.PubMedGoogle Scholar
  27. 27.
    Khaghani A, Tadjkarimi S, Al-Kattan K et al. Wrapping the anastomosis with omentum or an internal mammary artery pedicle does not improve bronchial healing after single lung transplantation: results of a randomized clinical trial J Heart Lung Transplant. 1994;13:767–73.PubMedGoogle Scholar
  28. 28.
    Trulock EP. Recipient selection. In Patterson GA. Cooper JD. editors. Chest surgery clinics of North America. Philadelphia. PA: 1993:1–18.Google Scholar
  29. 29.
    Kirk AJB, Colquhoun IW, Dark JH. Lung preservation: a review of current practice and future directions. Ann Thorac Surg. 1993;56:990–1000.PubMedCrossRefGoogle Scholar
  30. 30.
    Baumgartner WA. Myocardial and pulmonary protection: long-distance transport. Prog Cardiovasc. Dis. 1990;33:85–96.PubMedCrossRefGoogle Scholar
  31. 31.
    Colquhoun IW, Kirk AJB, Au J et al. Single-flush perfusion with modified Euro-Collin.s solution: experience in clinical lung preservation. J Heart Lung Transplant. 1992;11:S209–14.PubMedGoogle Scholar
  32. 32.
    Harjula A, Baldwin JC, Shumway NK. Donor deep hypothermia or donor pretreatment with prostaglandin E1 and single pulmonary artery flush for heart-lung graft preservation: an experimental primate study. Ann Thorac Surg. 1988;46:553–5.PubMedCrossRefGoogle Scholar
  33. 33.
    Bresticker MA, Lo Cicero J III. Oba J, Greene R. Successful extended lung preservation with UW solution. Transplantation. 1992;54:780–4.PubMedCrossRefGoogle Scholar
  34. 34.
    Locke TJ, Hooper TL, Flecknell PA, McGregor CGA. Preservation of the lung. Comparison of topical cooling and cold crystalloid pulmonary perfusion. J Thorac Cardiovasc Surg. 1988;96:789–95.PubMedGoogle Scholar
  35. 35.
    Waters PF. Single lung transplant: indications and technique. Semin Thorac Cardiovasc Surg. 1992;4:904.Google Scholar
  36. 36.
    Morgan E, Lima O, Goldberg M et al. Successful revascularization of totally ischemic bronchial autografts with omental pedicle flaps in dogs. J Thorac Cardiovasc. Surg. 1982;84:204–10.PubMedGoogle Scholar
  37. 37.
    Cooper JD, Pearson EG, Patterson GA et al. Technique of successful lung transplantation in humans. J Thorac Cardiovasc Surg. 1987;93:173–81.PubMedGoogle Scholar
  38. 38.
    Kaye MP, O’Connell JB, editors. Heart and lung transplantation 2000. Austin. TX: R. G. Landes: 1993.Google Scholar
  39. 39.
    Kawaguchi A, Gandjbakhch I. Pavie A et al. Heart and unilateral lung transplantation in patients with end-stage cardiopulmonary disease and previous thoracic operations. J Thorac Cardiovasc Surg. 1989;98:343–9.PubMedGoogle Scholar
  40. 40.
    Kendall SWH, Wallwork J. Heart-lung transplantation: indications and technique. Scmin Thorac Cardiovasc Surg. 1992;4:101–6.Google Scholar
  41. 41.
    Madden BP, Hodson ME, Tsang V et al. Intermediate-term results of heart lung transplantation tor cystic librosis. Lancet. 1992;339:1583–7.PubMedCrossRefGoogle Scholar
  42. 42.
    Yacoub MM, Banner NR, Khaghani Aet al. Heart lung transplantation for cystic fibrnsis and subsequent domino heart transplantation. J Heart Lung Transplant, 1990;9:459–67.Google Scholar
  43. 43.
    Baumgartner WA, Traill TA, Cameron DE et al. Unique aspects of heart and lung transplantation exhibited in the ‘domino-donor ‘operation. J Am Med Assoc. 1989;261:3121–5.CrossRefGoogle Scholar
  44. 44.
    Oaks TE, Aravot D, Dennis C et al. Domino heart transplantation: the Papworth experience. J Heart Lung Transplant. 1994;13:433–7.PubMedGoogle Scholar
  45. 45.
    Winton TL. Lung transplantation: donor selection. Semin Thorac Cardiovasc Surg. 1992;4:79–82.PubMedGoogle Scholar
  46. 46.
    Fairley JW, Hunt BJ, Glover GW, Radley-Smith RC, Yacoub MH. Unusual lymphoproliferative oropharyngeal lesions in heart and heart-lung transplant recipients. J Laryngol Otol. 1990;104:720–4.PubMedGoogle Scholar
  47. 47.
    Shennib H, Massard G, Gauthier Rand the Cystic Fibrosis Transplant Study Group. Single lung transplantation for cystic fibrosis: is it an option? J Heart Lung Transplant. 1993;12:288–93.PubMedGoogle Scholar
  48. 48.
    Cooper JD. The other lung-revisited. Chest. 1989;96:707–8.PubMedGoogle Scholar
  49. 49.
    Patterson GA, Maurer JR, Williams TJ and the Toronto Lung Transplant Group. Comparison of outcomes of double and single lung transplantation for obstructive lung disease. J Thorac Cardiovasc Surg. 1991;101:623–32.PubMedGoogle Scholar
  50. 50.
    Trulock EP, Egan TM, Kouchoukos NT and the Washington University Lung Transplant Group. Single lung transplantation for severe chronic obstructive pulmonary disease. Chest. 1989;96:738–42.PubMedGoogle Scholar
  51. 51.
    Dark JH, Patterson GA, Al-Jitaihawi AN et al. Experimental en bloc double-lung transplantation. Ann Thorac Surg. 1986;42:394–8.PubMedCrossRefGoogle Scholar
  52. 52.
    Kaiser LR, Pasque MK, Trulock HP et al. Bilateral sequential lung transplantation: the procedure of choice for double-lung replacement. Ann Thorac Surg. 1991;52:438–46.PubMedCrossRefGoogle Scholar
  53. 53.
    Pasque MK, Cooper JD, Kaiser LR et al. Improved technique for bilateral lung transplantation: rationale and initial clinical experience. Ann Thorac Surg. 1990;49:785–91.PubMedCrossRefGoogle Scholar
  54. 54.
    Patterson GA. Bilateral lung transplant: indications and technique. Semin Thorac Cardiovasc Surg. 1992;4:95–100.PubMedGoogle Scholar
  55. 55.
    Chamberlain D, Maurer J, Chaparro C, Idolor L. Evaluation of transbronchial lung biopsy specimens in the diagnosis of bronchiolitits obliterans after lung transplantation. J Heart Lung Transplant. 1994;13:963–71.PubMedGoogle Scholar
  56. 56.
    Smiley RM, Navedo AT, Kirby T, Schulman LL. Postoperative independent lung ventilation in a single-lung transplant recipient. Anesthesiology. 1991;74:1144–8.PubMedCrossRefGoogle Scholar
  57. 57.
    Maurer JR. Snell G, de Hoyos A, Kesten S, Winton T. Outcomes of lung transplantation using three different cytomegalovirus prophylactic regimens. Transplant Proc. 1993;25:1434–5.PubMedGoogle Scholar
  58. 58.
    Miyoshi S, Schaefers H-J, Trulock EP et al. Donor selection for single and double lung transplantation. Chest size matching and other factors influencing posttransplantation vital capacity. Chest. 1990;98:308–13.PubMedGoogle Scholar
  59. 59.
    Egan TF, Detterbeck FC, Mill MR et al. Improved results of lung transplantation for patients with cystic fibrosis. J Thorac Cardiovasc Surg. 1995;109:224–35.PubMedCrossRefGoogle Scholar
  60. 60.
    Emery RW, Eales F, Von Rueden TJ, Joyce LD. The cardiothoracic donor. Cardiac Surgery: Slate of the Art Reviews. 1988;2:547–54.Google Scholar
  61. 61.
    Griflith BP, Zenati M. The pulmonary donor Clin Chest Med. 1990;11:217–26.Google Scholar
  62. 62.
    Olesen MP, Emery RW, Martin S. Management of the cardiothoracic organ donor. Cardiac Surgery: State of the Art Reviews. 1988;2:541–5.Google Scholar
  63. 63.
    Waters PF. Lung transplantation: recipient selection. Scmin Thorac Cardiovasc Surg. 1992;4:73–8.Google Scholar
  64. 64.
    Kron IL, Tribble CG, Kern JA et al. Successful transplantation of marginally acceptable thoracic organs. Ann Surg. 1993;217:518–24.PubMedCrossRefGoogle Scholar
  65. 65.
    Sundaresan S, Semenkovich J, Ochoa L et al. Successful outcome of lung transplantation is not compromised by the use of marginal donor lungs. J Thorac Cardiovasc Surg. 1995;109:1075–80.PubMedCrossRefGoogle Scholar
  66. 66.
    Nezu K, Kushibe K, Tojo T et al. Protection against lipid peroxidation induced during preservation of lungs for transplantation. J Heart Lung Transplant. 1994;13:998–1002.PubMedGoogle Scholar
  67. 67.
    Robin ED. The kingdom of the near-dead. The shortened unnatural life history of primary pulmonary hypertension. Chest. 1987;92:330–4.PubMedGoogle Scholar
  68. 68.
    Kerem E, Reisman J, Corey M, Canny GJ, Levison H. Prediction of mortality in patients with cystic librosis. N Engl J Med. 1992;326:1187–91.PubMedCrossRefGoogle Scholar
  69. 69.
    Trulock EP. Management of lung transplant rejection. Chest. 1993;103:1566–76.PubMedGoogle Scholar
  70. 70.
    Manzelti JD, Hoffman LA, Sereika SM, Sciurba FC, Griflith BP. Exercise, education, and quality of life in lung transplant candidates. J Heart Lung Transplant. 1994;13:297–305.Google Scholar
  71. 71.
    Cooper JD, Trulock EP, Triantafillou AN et al. Bilateral pneumonectomy (volume reduction) for chronic obstructive pulmonary disease. J Thorac Cardiovasc Surg. 1995;109:106–19.PubMedCrossRefGoogle Scholar
  72. 72.
    Patterson GA, Todd TR, Cooper JD and the Toronto Lung Transplant Group. Airway complications alter double lung transplantation. J Thorac Cardiovasc Surg. 1990;99:14–21.PubMedGoogle Scholar
  73. 73.
    Ramirez J, Patterson GA. Airway complications after lung transplantation. Semin Thorac Cardiovasc Surg. 1992;4:147–53.PubMedGoogle Scholar
  74. 74.
    Metras D, Henri Metras-a pioneer in lung transplantation. J Heart Lung Transplant. 1992;11:1213–16.PubMedGoogle Scholar
  75. 75.
    de Hoyos A, Demajo W, Snell G et al. Preoperative prediction for the use of cardiopulmonary bypass in lung transplantation. J Thorac Cardiovasc Surg. 1993;106:787–96.PubMedGoogle Scholar
  76. 76.
    Gallo JA. Anesthesia for thoracic transplantation. Cardiac Surgery: Stale of the Art Reviews. 1988;2:555–63.Google Scholar
  77. 77.
    Triantafillou AN. Anesthetic considerations. In Patterson GA. Cooper JD, editors. Chest surgery clinics of North America. Philadelphia, PA; 1993:49–73.Google Scholar
  78. 78.
    Bando K, Paradis IL, Komatsu K et al. Analysis of time-dependent risks for infection, rejection, and death after pulmonary transplantation. J Thorac Cardiovasc. Surg. 1995;109:49–59.PubMedCrossRefGoogle Scholar
  79. 79.
    de Hoyos A, Maurer JR. Complications following lung transplantation. Semin Thorac Cardiovasc Surg. 1992;4:132–46.PubMedGoogle Scholar
  80. 80.
    Chaparro C, Maurer JR, Chamberlain Det al. Causes of death in lung transplant recipients. J Heart Lung Transplant. 1994;13:758–66.PubMedGoogle Scholar
  81. 81.
    Griffith BP, Paradis IL, ZeeviT A et al. Immunologically mediated disease of the airways after pulmonary transplantation. Ann Surg. 1988;208:371–8.PubMedCrossRefGoogle Scholar
  82. 82.
    Paradis I, Yousem S, Griffith B. Airway obstruction and bronchiolitis obliterans after lung transplantation. Clin Chest Med. 1993;14:751–63.PubMedGoogle Scholar
  83. 83.
    Marelli D, Paul A, Nguyen DMet al. The reversibility of impaired mucociliary function after lung transplantation. J Thorac Cardiovasc Surg. 1991;102:908–12.PubMedGoogle Scholar
  84. 84.
    Kirby TJ, Mehta A, Rice TW, Gephardt GN. Diagnosis and management of acute and chronic lung rejection. Semin Thorac Cardiovasc Surg. 1992;4:126–31.PubMedGoogle Scholar
  85. 85.
    Millet B, Higenbottam TW, Flower CDR, Stewart S, Wallwork J. The radiographic appearances of infection and acute rejection of the lung after heart-lung transplantation. Am Rev Respir Dis. 1989;140:62–7.PubMedGoogle Scholar
  86. 86.
    Cooper JD, Billingham M, Egan T et al. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. J Heart Lung Transplant. 1993;12:713–16.PubMedGoogle Scholar
  87. 87.
    Day JD, Hutchins GM, Hruban RH. Grading pulmonary rejection: A proposal for a simplified system. J Heart Lung Transplant. 1994;13:734–7.PubMedGoogle Scholar
  88. 88.
    de Hoyos A, Chamberlain D, Schvartzman R et al. Prospective assessment of a standardized pathologic grading system for acute rejection in lung transplantation. Chest. 1993;103:1813–18.PubMedGoogle Scholar
  89. 89.
    Higenbottam T, Hutter JA, Stewart S, Wallwork J. Transbronchial biopsy has eliminated the need for endomyocardial biopsy in heart-lung recipients. J Heart Transplant. 1988;7:435–9.PubMedGoogle Scholar
  90. 90.
    Hutter JA, Stewart S, Higenbottam T, Scott JP, Wallwork J. Histologic changes in heart-lung transplant recipients during rejection episodes and at routine biopsy. J Heart Transplant. 1988;7:440–4.PubMedGoogle Scholar
  91. 91.
    Hruban RH, Beschorner WE, Baumgartner WA et al. Diagnosis of lung allograft rejection by bronchial intraepilhelial Leu-7 positive T lymphocytes. J Thorac Cardiovasc Surg. 1988;96:939–46.PubMedGoogle Scholar
  92. 92.
    Ross DJ, Yeh AY, Nathan SD el al. Differential soluble interleukin-2R levels in bilateral bronchoalveolar lavage after single lung transplantation. J Heart Lung Transplant. 1994;1.3:972–9.Google Scholar
  93. 93.
    Rao PN, Zeevi A, Snyder Jet al. Monitoring of acute lung rejection and infection by bronchoalveolar lavage and plasma levels of hyaluronic acid in clinical lung transplantation. J Heart Lung Transplant. 1994;13:958–62.PubMedGoogle Scholar
  94. 94.
    Fukuse T, Hirai T, Yokomise H et al. Combined therapy with FK-506 and cy-closporin for canine lung allotransplantation: immunosuppressive effects and blood trough levels. J Heart Lung Transplant. 1993;12:941–7.PubMedGoogle Scholar
  95. 95.
    Griflith BP, Bando K, Hardesty RL et al. A prospective randomized trial of FK506 versus cyclosporin after human pulmonary transplantation. Transplantation. 1994;57:848–51.CrossRefGoogle Scholar
  96. 96.
    Shennib H, Massard G, Reynaud M, Noirclerc M. Efficacy of OKT3 therapy for acute rejection in isolated lung transplantation. J Heart Lung Transplant. 1994;13:514–19.PubMedGoogle Scholar
  97. 97.
    Shennib H, Mercado M, Nguyen D et al. Successful treatment of steroid-resistant double-lung allograft rejection with Orthoclone OKT3. Am Rev Respir Dis. 1991;144:224–6.PubMedGoogle Scholar
  98. 98.
    Duncan AJ, Dummer JS, Paradis IL et al. Cytomegalovirus infection and survival in lung transplant recipients. J Heart Lung Transplant. 1991;10:638–46.PubMedGoogle Scholar
  99. 99.
    Frank I, Friedman HM. Progress in the treatment of cytomegalovirus pneumonia. Ann Intern Med. 1988;109:769–71.PubMedGoogle Scholar
  100. 100.
    Gould FK, Freeman R, Taylor CE et al. Prophylaxis and management of cytomegalovirus pneumonitis after lung transplantation: a review of experience in one center. J Heart Lung Transplant. 1993;12:695–9.PubMedGoogle Scholar
  101. 101.
    Martin M. Update on cytomegalovirus infection in solid-organ transplantalion. Transplant Proc. 1993;15:1–40.Google Scholar
  102. 102.
    Maurer JR, Tullis E, Scavuzzo M, Patterson GA. Cytomegalovirus infection in isolated lung transplantations. J Heart Lung Transplant. 1991;10:647–9.PubMedGoogle Scholar
  103. 103.
    Dummer JS, White LT, Ho M et al. Morbidity of cytomegalovirus infection in recipients of heart or heart-lung transplants who received cyclosporin. J Infect Dis. 1985;152:1182–91.PubMedGoogle Scholar
  104. 104.
    Noirderc M, Shennib H, Giudicelli R et al. Size matching in lung transplantation. J Heart Lung Transplant. 1992;11:S203–8.Google Scholar
  105. 105.
    Rubin RH. The indirect effects of cytomegalovirus infection on the outcome of organ transplantation. J Am Med Assoc. 1989;261:3607–9.CrossRefGoogle Scholar
  106. 106.
    Novick RJ, Menkis AH, McKenzie FN, Reid KR, Ahmad D. Should heart-lung transplant donors and recipients be matched according to cytomegalovirus serologie status? J Heart Transplant. 1990;9:699–706.PubMedGoogle Scholar
  107. 107.
    Morrish WF, Herman SJ, Weisbrod GL and the Toronto Lung Transplant Group. Bronchiolitis obliterans after lung transplantation: findings at chest radiography and high-resolution CT. Radiology. 1991;179:487–90.PubMedGoogle Scholar
  108. 108.
    Sheil AGR, Disney APS, Mathew TG, Amiss N, Excell L. Malignancy following renal transplantalion. Transplant Proc. 1992;24:1946–7.PubMedGoogle Scholar
  109. 109.
    Rich GM, Mudge GH, Laffel GL, LeBolf MS. Cyclosporine A and prednisoneassociated osteoporosis in heart transplant recipients. J Heart Lung Transplant. 1992;11:950–8.PubMedGoogle Scholar
  110. 110.
    Corris PA, Dark JH. Aetiology of asthma: lessons from lung transplantation. Lancet. 1993;341:1369–77.PubMedCrossRefGoogle Scholar
  111. 111.
    Dowling RD, Zenati M, Pasculle AW et al. Antibiotic treatment of donors prevents experimental pneumonia in recipients of canine lung allotransplanlation. Surg Forum. 1989;40:372–4.Google Scholar
  112. 112.
    Mentzer SJ, Reilly JJ Jr, Caplan AL, Sugarbaker DJ. Ethical considerations in lung retransplantation. J Heart Lung Transplant. 1994;13:56–]Section 4 4 Current and Future Advances in Thoracic Organ Replacement Advances in Control of the Immune ResponsePubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1996

Authors and Affiliations

  • G. B. Haasler
  • J. D. Hosenpud

There are no affiliations available

Personalised recommendations